Pregnant Women Advised to Avoid Alcohol and Cannabis for Safety

Pregnant women are advised to completely avoid both alcohol and cannabis, as emerging evidence highlights significant risks to their health and that of their babies. The Centers for Disease Control and Prevention (CDC) and the American College of Obstetricians and Gynecologists (ACOG) emphasize that no amount of alcohol is safe during pregnancy, with abstinence being the most effective choice for ensuring the well-being of both mother and child.

Research indicates that prenatal alcohol consumption is linked to a variety of adverse outcomes, including low birth weight, preterm birth, and even neonatal intensive care unit admissions. Current statistics reveal that between 13% and 14% of pregnant women in the United States report consuming alcohol, with approximately 5% engaging in binge drinking. This represents a substantial number of pregnancies at risk, as many women may not recognize their pregnancy until later, often due to unplanned circumstances.

The implications of alcohol exposure during pregnancy can be severe, leading to a spectrum of lifelong conditions known as Fetal Alcohol Spectrum Disorders (FASD). These disorders can manifest as growth restrictions and neurodevelopmental impairments, even in the absence of visible facial features commonly associated with FASD. The CDC underscores that prenatal screening for alcohol use should be a routine part of prenatal care, aiming to identify and support women who may be at risk.

Recent analyses also show that the use of cannabis during pregnancy is on the rise. Data from the National Survey on Drug Use and Health indicates that 6.8% of pregnant women reported using marijuana between 2021 and 2023, with higher prevalence noted during the first trimester. Cannabis use is associated with increased odds of low birth weight and preterm birth, as well as complications such as gestational hypertension and placental abruption.

Dr. Yasmin Hurd, a prominent researcher at Mount Sinai Medical Center, warns that misinformation surrounding the safety of cannabis use during pregnancy is rampant. She stresses the need for accurate public information, noting that cannabis products have become more potent over the years, which may increase risks for developing children.

The risks associated with cannabis use are compounded when combined with other substances. Studies indicate that pregnant women who use both cannabis and tobacco face amplified risks of adverse maternal and infant health outcomes. This underscores the importance of comprehensive approaches to substance use during pregnancy, recognizing that many women may use multiple substances simultaneously.

For those with existing conditions such as opioid use disorder, the CDC recommends medication-assisted treatment as a means of improving outcomes for both the mother and child. Starting treatment early in pregnancy is crucial to mitigating risks associated with substance use.

While the long-term effects of cannabis use during pregnancy are still being studied, the consensus remains clear: the safest course of action for pregnant and breastfeeding women is to refrain from using both alcohol and cannabis. Ongoing research continues to explore the full range of potential risks, with the aim of better informing healthcare practices and improving maternal and child health outcomes globally.